ClearPoint Neuro (CLPT) Shareholder's Equity (2011 - 2026)

ClearPoint Neuro (CLPT) Shareholder's Equity (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 52.06 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 22.98 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 49.20 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 26.10 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 10.33 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 13.34 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 2.96 Bn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 10.67 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 7.20 Bn
10 ClearPoint Neuro 524.46 Mn 488.86 Mn 7.76 Mn 18.84 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 18.84 Mn
Dec 31, 2025 28.02 Mn
Sep 30, 2025 15.87 Mn
Jun 30, 2025 19.74 Mn
Mar 31, 2025 19.99 Mn
Dec 31, 2024 25.39 Mn
Sep 30, 2024 29.00 Mn
Jun 30, 2024 32.13 Mn
Mar 31, 2024 34.58 Mn
Dec 31, 2023 21.17 Mn
Sep 30, 2023 24.09 Mn
Jun 30, 2023 27.41 Mn
Mar 31, 2023 32.58 Mn
Dec 31, 2022 36.89 Mn
Sep 30, 2022 39.88 Mn
Jun 30, 2022 42.82 Mn
Mar 31, 2022 45.73 Mn
Dec 31, 2021 48.79 Mn
Sep 30, 2021 44.12 Mn
Jun 30, 2021 47.97 Mn